Spectrum Pharmaceuticals Receives CRL from FDA for EVOMELA for Injection By: Benzinga via Benzinga October 23, 2015 at 04:22 AM EDT Spectrum Pharmaceuticals (Nasdaq: SPPI) announced today that it has received a Complete Response Letter from the U.S. ... Read More >> Related Stocks: Ligand Pharm Spectrum Pharma Inc